Skip to main content
Log in

PAF receptor structure: A hypothesis

  • PAF Receptor and Antagonists
  • Review
  • Published:
Lipids

Abstract

Different hypotheses of the structure of platelet-activating factor (PAF) receptor based on structure-activity relationships of agonists and antagonists are reviewed. For an agonistic effect, strong hydrophobic interactions and an ether function are required in position-1 of the glycerol backbone; chain length limitations and steric hindrance demand a small group in position-2. The unusual structural properties of non-PAF-like antagonists required 3-D electrostatic potential calculations. This method applied to seven potent antagonists suggests a strong “Cache-oreilles” (ear-muff) effect,i.e., two strong electronegative wells (isocontour at −10 Kcal/mole) are located at 180° to each other and at a relatively constant distance. Initial consideration of the “Cache-oreilles” effect implied the structure of a bipolarized cylinder of 10–12 Å diameter for the receptor. However, very recent results on studies with agonists and antagonists structurally similar to PAF suggest that the receptor may in fact be a multi-polarized cylinder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

3-D:

three-dimensional (electrostatic potential map)

PAF:

platelet-activating factor

QSAR:

quantitative structure activity relationship

References

  1. Braquet, P., and Godfroid, J.J. (1986)Trends Pharmacol. Sci. 7, 397–403.

    Article  CAS  Google Scholar 

  2. Braquet, P., and Godfroid, J.J. (1987) inPlatelet Activating Factor and Related Lipid Mediators (Snyder, F., ed.) pp. 191–235, Plenum Press, New York.

    Google Scholar 

  3. Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1987)Pharmacol. Rev. 39, 97–145.

    PubMed  CAS  Google Scholar 

  4. Houlihan, W.J. (1990) inPlatelet Activating Factor and Immune Diseases (Houlihan, W.J., ed.) pp. 31–75, Marcel Dekker, New York.

    Google Scholar 

  5. Valone, F.M. (1987) inPlatelet Activating Factor and Related Lipid Mediators (Snyder, F., ed.) pp. 137–151, Plenum Press, New York.

    Google Scholar 

  6. Godfroid, J.J., and Braquet, P. (1986)Trends Pharmacol. Sci. 7, 368–373.

    Article  CAS  Google Scholar 

  7. Dive, G., Godfroid, J.J., Lamotte-Brasseur, J., Batt, J.P., Heymans, F., Dupont, L., and Braquet, P. (1989)J. Lipid Mediators 1, 201–215.

    CAS  Google Scholar 

  8. Godfroid, J.J., and Dive, G. (1990) inPlatelet Activating Factor and Immune Diseases (Houlihan, W.J., ed.) pp. 15–30, Marcel Dekker, New York.

    Google Scholar 

  9. Heymans, F., Michel, E., Borrel, M.C., Wichrowski, B., and Godfroid, J.J. (1981)C.R. Acad. Sci. (Paris) 293, 49–52.

    CAS  Google Scholar 

  10. Heymans, F., Michel, E., Borrel, M.C., Wichrowski, B., Godfroid, J.J., Convert, O., Coëffier, E., Tencé, M., and Benveniste, J. (1981)Biochim. Biophys. Acta 666, 230–237.

    PubMed  CAS  Google Scholar 

  11. Wykle, R.L., Miller, C.H., Lewis, J.C., Schmitt, J.D., Surles, J.R., Piantadosi, C., and O'Flaherty, J.T. (1981)Biochem. Biophys. Res. Commun. 100, 1651–1658.

    Article  PubMed  CAS  Google Scholar 

  12. Tencé, M., Coëffier, E., Heymans, F., Polonsky, J., Godfroid, J.J., and Benveniste, J. (1981)Biochimie 63, 723–727.

    PubMed  Google Scholar 

  13. Godfroid, J.J., Broquet, C., Jouquey, S., Lebbar, M., Heymans, F., Redeuilh, C., Steiner, E., Michel, E., Coëffier, E., Fichelle, J., and Worcel, M. (1987)J. Med. Chem. 30, 792–797.

    Article  PubMed  CAS  Google Scholar 

  14. Heymans, F., Steiner, E., Jouquey, S., and Godfroid, J.J. (1989)J. Lipid Mediators 1, 303–312.

    CAS  Google Scholar 

  15. Wichrowski, B., Jouquey, S., Broquet, C., Heymans, F., Godfroid, J.J., and Worcel, M. (1988)J. Med. Chem. 31, 410–415.

    Article  PubMed  CAS  Google Scholar 

  16. Tokumara, A., Homma, M., and Hanahan, D.J. (1985)J. Biol. Chem. 260, 12710–12714.

    Google Scholar 

  17. Wissner, A., Shaub, R.E., Sum, P.E., Kohler, C.A., and Goldstein, B.M. (1985)J. Med. Chem. 29, 328–333.

    Article  Google Scholar 

  18. Furno-De Winter, A., Broquet, C., Haelters, J.-P., Massicot, F., Sturtz, G., and Godfroid, J.-J. (1991)J. Lipid Mediators 3, 289–300.

    CAS  Google Scholar 

  19. Favre, E., Heymans, F., Redeuilh, C., Batt, J.-P., Massicot, F., Braquet, P., and Godfroid, J.-J. (1991)J. Lipid Mediators, in press.

  20. Borrel, M.C. (1984) Ph.D. Thesis, University Paris 7, Paris, pp. 156–174.

  21. Ohno, M., Fujita, K., Nakai, H., Kobayashi, S., Yamashita, M., Inone, K., and Nojima, S. (1983) inPlatelet Activating Factor and Structurally Related Ether Lipids (Benveniste, J., and Arnoux, B., eds.) pp. 9–20, Elsevier, Amsterdam.

    Google Scholar 

  22. Coëffier, E., Borrel, M.C., Lefort, J., Chignard, M., Broquet, C., Heymans, F., Godfroid, J.J., and Vargaftig, B.B. (1986)Eur. J. Pharmacol. 131, 179–188.

    Article  PubMed  Google Scholar 

  23. Lamotte-Brasseur, J., Dive, G., Lamouri, A., Heymans, F., and Godfroid, J.-J. (1991)Biochim. Biophys. Acta 1085, 91–105.

    PubMed  CAS  Google Scholar 

  24. Batt, J.-P., Lamouri, A., Tavet, F., Heymans, F., Dive, G., and Godfroid, J.-J. (1991)J. Lipid Mediators, in press.

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Godfroid, J.J., Dive, G., Lamotte-Brasseur, J. et al. PAF receptor structure: A hypothesis. Lipids 26, 1162–1166 (1991). https://doi.org/10.1007/BF02536523

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02536523

Keywords

Navigation